13 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
given to such term in Section 0 of this Agreement.
“Quality Agreement” has the meaning given to such term in Section 7.4 of this Agreement.
“Recall … ” means with respect to the Product, a “recall”, “correction” or “market” withdrawal, as those terms (or their equivalents) are defined by Applicable Law
8-K
EX-1.1
aqonm0ze6hk 3dip3wqu
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
424B5
2cq56r8v nncm0kr
30 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
EX-1.1
esvf9 2n3l
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
6-K
jsgx8syr n8uan2s84
22 Jul 05
Current report (foreign)
12:00am
- Prev
- 1
- Next